Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $10.37 and last traded at $10.28, with a volume of 165516 shares changing hands. The stock had previously closed at $10.32.
Cybin Trading Down 0.4 %
The stock has a market cap of $1.53 billion and a P/E ratio of -43.00. The business’s 50 day moving average price is $10.32 and its two-hundred day moving average price is $4.33.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Further Reading
- Five stocks we like better than Cybin
- The Significance of Brokerage Rankings in Stock Selection
- The Great CPU Race: AMD and Intel Battle for Dominance
- Why Are These Companies Considered Blue Chips?
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- What is a Death Cross in Stocks?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
